Statistics
Publications
2
Citations
37
H-Index
2
Active since
2024
Affiliations
Chongqing Cancer Hospital(Current)
Yu Chen is an author at Chongqing Cancer Hospital specializing in sorafenib therapy, tumor progression, and hepatocellular carcinoma.
Publications per year
2024–2024
2
2
GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
Yu Zhou, Huakan Zhao, Ran Ren et al. · Theranostics · 2024 · 16 citations · Full text
Medicine, Oncology, Pharmacology +17
1–2 of 2